1️⃣ Insight Summary
We’re watching for a healthy pullback into the $31–$30.10 zone on
2️⃣ Trade Parameters
Bias: Long
Entry: Around $31.00–$30.10
Stop Loss: Below $21.00, with a hard stop at $19.00 if price breaks structure
Take Profit 1: $44.00
Take Profit 2: $59.71
3️⃣ Key Notes
✅ Fundamentals are solid: Revenue ~1.48B, net income ~200M, market cap ~113B. 2024 marked the first profitable year. Debt sits @ $11M, while free cash flow is ~$1.098B—low debt relative to cash flow.
✅ Ratings & margins: ~14% free cash margin, realistic forward estimates, stable beta (~3.2) and 0.15 EPS.
✅ Risk/Reward profile: Entry gives ~10–11 points of downside vs. ~13–29 points upside to targets.
✅ Technical scenario: A pullback to $30–31 acting as support would confirm our bias—monitor price action closely in this zone.
✅ Sector tailwinds: Continued momentum in telehealth, mental health, and AI-driven medical services supports upside potential.
4️⃣ Follow‑up Note
If
Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible.
Disclaimer: This is not financial advice. Always conduct your own research. This content may include enhancements made using AI.
I work with busy founders and executives who are tired of ad hoc trading results. I give you a clear, rules based trading system built from my own years in the market, so you can protect capital, compound it, and understand trading like a real business.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.
I work with busy founders and executives who are tired of ad hoc trading results. I give you a clear, rules based trading system built from my own years in the market, so you can protect capital, compound it, and understand trading like a real business.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.
